Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

212 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Towards a universal second-line fixed-dose combination ART.
Boyd MA, Cooper DA, Gilks CF. Boyd MA, et al. Among authors: gilks cf. Lancet HIV. 2018 Jan;5(1):e3-e5. doi: 10.1016/S2352-3018(17)30180-7. Epub 2017 Oct 6. Lancet HIV. 2018. PMID: 28993181 No abstract available.
Second-line antiretroviral therapy: so much to be done.
Assefa Y, Gilks CF. Assefa Y, et al. Among authors: gilks cf. Lancet HIV. 2017 Oct;4(10):e424-e425. doi: 10.1016/S2352-3018(17)30112-1. Epub 2017 Aug 4. Lancet HIV. 2017. PMID: 28784425 No abstract available.
Autopsies and better data on causes of death in Africa.
Rampatige R, Gilks CF. Rampatige R, et al. Among authors: gilks cf. Lancet Infect Dis. 2015 May;15(5):492-4. doi: 10.1016/S1473-3099(15)70096-4. Epub 2015 Mar 10. Lancet Infect Dis. 2015. PMID: 25765218 No abstract available.
Rapid accumulation of HIV-1 thymidine analogue mutations and phenotypic impact following prolonged viral failure on zidovudine-based first-line ART in sub-Saharan Africa.
Goodall RL, Dunn DT, Nkurunziza P, Mugarura L, Pattery T, Munderi P, Kityo C, Gilks C, Kaleebu P, Pillay D, Gupta RK; DART Virology Group. Goodall RL, et al. J Antimicrob Chemother. 2017 May 1;72(5):1450-1455. doi: 10.1093/jac/dkw583. J Antimicrob Chemother. 2017. PMID: 28160504 Free PMC article.
The virological durability of first-line ART among HIV-positive adult patients in resource limited settings without virological monitoring: a retrospective analysis of DART trial data.
Dolling DI, Goodall RL, Chirara M, Hakim J, Nkurunziza P, Munderi P, Eram D, Tumukunde D, Spyer MJ, Gilks CF, Kaleebu P, Dunn DT, Pillay D; DART Virology Group. Dolling DI, et al. Among authors: gilks cf. BMC Infect Dis. 2017 Feb 21;17(1):160. doi: 10.1186/s12879-017-2266-3. BMC Infect Dis. 2017. PMID: 28222702 Free PMC article.
High level of viral suppression and low switch rate to second-line antiretroviral therapy among HIV-infected adult patients followed over five years: retrospective analysis of the DART trial.
Kityo C, Gibb DM, Gilks CF, Goodall RL, Mambule I, Kaleebu P, Pillay D, Kasirye R, Mugyenyi P, Walker AS, Dunn DT; DART Trial Team. Kityo C, et al. Among authors: gilks cf. PLoS One. 2014 Mar 13;9(3):e90772. doi: 10.1371/journal.pone.0090772. eCollection 2014. PLoS One. 2014. PMID: 24625508 Free PMC article. Clinical Trial.
212 results